109 related articles for article (PubMed ID: 31545289)
1. RAD54B potentiates tumor growth and predicts poor prognosis of patients with luminal A breast cancer.
Zhang Z; Li X; Han Y; Ji T; Huang X; Gao Q; Ma D
Biomed Pharmacother; 2019 Oct; 118():109341. PubMed ID: 31545289
[TBL] [Abstract][Full Text] [Related]
2. Integrated study of miR-215 promoting breast cancer cell apoptosis by targeting RAD54B.
Wang M; Liao J; Tan C; Zhou H; Wang J; Wang K; Li Y; Wu W
J Cell Mol Med; 2021 Apr; 25(7):3327-3338. PubMed ID: 33635591
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of RAD54B suppresses proliferation and promotes apoptosis in hepatoma cells.
Wang R; Li Y; Chen Y; Wang L; Wu Q; Guo Y; Li Y; Liu J; Wang L
Oncol Rep; 2018 Sep; 40(3):1233-1242. PubMed ID: 29956808
[TBL] [Abstract][Full Text] [Related]
4. High RAD54B expression: an independent predictor of postoperative distant recurrence in colorectal cancer patients.
Nagai Y; Yamamoto Y; Yasuhara T; Hata K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Yamanaka T; Miyagawa K; Watanabe T
Oncotarget; 2015 Aug; 6(25):21064-73. PubMed ID: 26046797
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of CKS2 is associated with a poor prognosis and promotes cell proliferation and invasion in breast cancer.
Huang N; Wu Z; Hong H; Wang X; Yang F; Li H
Mol Med Rep; 2019 Jun; 19(6):4761-4769. PubMed ID: 30957190
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of RAD54B expression reduces cell proliferation and induces apoptosis in lung cancer cells.
Xu C; Liu D; Mei H; Hu J; Luo M
J Int Med Res; 2019 Nov; 47(11):5650-5659. PubMed ID: 31558081
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic Acid Receptor 6 (LPAR6) Expression and Prospective Signaling Pathway Analysis in Breast Cancer.
Tao K; Guo S; Chen R; Yang C; Jian L; Yu H; Liu S
Mol Diagn Ther; 2019 Feb; 23(1):127-138. PubMed ID: 30694446
[TBL] [Abstract][Full Text] [Related]
8. Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification.
Liu Z; Liu J; Liu R; Xue M; Zhang W; Zhao X; Zhu J; Xia P
BMC Cancer; 2021 Apr; 21(1):367. PubMed ID: 33827486
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of PBX1 and EMP2 as Prognostic Biomarkers in Estrogen Receptor-Negative Breast Cancer via Data Mining.
Qiu Y; Lu G; Wu Y
J Comput Biol; 2020 Oct; 27(10):1509-1518. PubMed ID: 32216630
[TBL] [Abstract][Full Text] [Related]
10. MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1.
Yao Y; Hu J; Shen Z; Yao R; Liu S; Li Y; Cong H; Wang X; Qiu W; Yue L
J Cell Mol Med; 2015 Apr; 19(4):760-9. PubMed ID: 25639535
[TBL] [Abstract][Full Text] [Related]
11. Down-regulated expression of LINC00518 prevents epithelial cell growth and metastasis in breast cancer through the inhibition of CDX2 methylation and the Wnt signaling pathway.
Wang HB; Wei H; Wang JS; Li L; Chen AY; Li ZG
Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):708-723. PubMed ID: 30611858
[TBL] [Abstract][Full Text] [Related]
12. Rad54B targeting to DNA double-strand break repair sites requires complex formation with S100A11.
Murzik U; Hemmerich P; Weidtkamp-Peters S; Ulbricht T; Bussen W; Hentschel J; von Eggeling F; Melle C
Mol Biol Cell; 2008 Jul; 19(7):2926-35. PubMed ID: 18463164
[TBL] [Abstract][Full Text] [Related]
13. The Overexpression of FEN1 and RAD54B May Act as Independent Prognostic Factors of Lung Adenocarcinoma.
Hwang JC; Sung WW; Tu HP; Hsieh KC; Yeh CM; Chen CJ; Tai HC; Hsu CT; Shieh GS; Chang JG; Yeh KT; Liu TC
PLoS One; 2015; 10(10):e0139435. PubMed ID: 26431531
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of DHCR7 as a diagnostic biomarker involved in the proliferation and mitochondrial function of breast cancer.
Wang Y; Fan J; Liu Y; Du J; Liang B; Wang H; Song Z
Aging (Albany NY); 2024 Mar; 16(7):5967-5986. PubMed ID: 38526324
[TBL] [Abstract][Full Text] [Related]
15. AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer.
Cao L; Xu C; Xiang G; Liu F; Liu X; Li C; Liu J; Meng Q; Jiao J; Niu Y
Mol Cancer; 2018 Sep; 17(1):136. PubMed ID: 30217192
[TBL] [Abstract][Full Text] [Related]
16. Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer.
Yuan SS; Hou MF; Hsieh YC; Huang CY; Lee YC; Chen YJ; Lo S
J Natl Cancer Inst; 2012 Oct; 104(19):1485-502. PubMed ID: 22914783
[TBL] [Abstract][Full Text] [Related]
17. MiR-182-5p Knockdown Targeting PTEN Inhibits Cell Proliferation and Invasion of Breast Cancer Cells.
Zhao YS; Yang WC; Xin HW; Han JX; Ma SG
Yonsei Med J; 2019 Feb; 60(2):148-157. PubMed ID: 30666836
[TBL] [Abstract][Full Text] [Related]
18. Mutations of a novel human RAD54 homologue, RAD54B, in primary cancer.
Hiramoto T; Nakanishi T; Sumiyoshi T; Fukuda T; Matsuura S; Tauchi H; Komatsu K; Shibasaki Y; Inui H; Watatani M; Yasutomi M; Sumii K; Kajiyama G; Kamada N; Miyagawa K; Kamiya K
Oncogene; 1999 Jun; 18(22):3422-6. PubMed ID: 10362364
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
Deng X; Zhao Y; Wu X; Song G
Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA circMYO9B facilitates breast cancer cell proliferation and invasiveness via upregulating FOXP4 expression by sponging miR-4316.
Wang N; Gu Y; Li L; Wang F; Lv P; Xiong Y; Qiu X
Arch Biochem Biophys; 2018 Sep; 653():63-70. PubMed ID: 29702064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
